Testosterone Undeconate (Nebido-R, BAY86-5037)
Pre-clinicalCompleted 0 watching 0 views this week๐ค Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypogonadism
Conditions
Hypogonadism
Trial Timeline
Jun 1, 2007 โ Oct 1, 2008
NCT ID
NCT00847314About Testosterone Undeconate (Nebido-R, BAY86-5037)
Testosterone Undeconate (Nebido-R, BAY86-5037) is a pre-clinical stage product being developed by Bayer for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT00847314. Target conditions include Hypogonadism.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00847314 | Pre-clinical | Completed |
| NCT00838838 | Pre-clinical | Completed |
Competing Products
20 competing products in Hypogonadism